Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

14,539 total articles

Suja Life launches IPO roadshow, sets price range at $21-$24 per share

Suja Life launches IPO roadshow, sets price range at $21-$24 per share

Suja Life, Inc. has begun its initial public offering roadshow after filing a registration statement with the SEC. The company is offering 8,888,889 shares of Class A common stock, with an expected price range of $21.00 to $24.00 per share. Suja Life and a selling stockholder have granted underwriters options to purchase additional shares. Proceeds…

HawkEye 360 Sets IPO Range That Implies Up to $2.42 Billion Valuation

HawkEye 360 Sets IPO Range That Implies Up to $2.42 Billion Valuation

HawkEye 360 filed papers in the United States indicating it aims to raise as much as $416 million through an initial public offering, pricing 16 million shares between $24 and $26. The filing implies a company valuation of up to $2.42 billion. The Herndon, Virginia firm plans to list on the New York Stock Exchange under the symbol HAWK, with severa…

BofA Questions 'Sell in May' Advice, Points to Late-Summer Vulnerability

BofA Questions 'Sell in May' Advice, Points to Late-Summer Vulnerability

Bank of America strategists Paul Ciana and Jonathan Hartley caution that the common 'sell in May and go away' rule misses important intra-season patterns. Their analysis of S&P 500 returns since 1928 shows the May-October six-month stretch underperforms November-April on average, but the shortfall is concentrated in August-October. BofA argues inve…

HawkEye 360 Seeks $2.42 Billion Valuation in U.S. IPO

HawkEye 360 Seeks $2.42 Billion Valuation in U.S. IPO

HawkEye 360, a Herndon, Virginia-based space analytics firm, has filed for a U.S. initial public offering seeking up to $416 million and targeting a valuation of as much as $2.42 billion. The company plans to offer 16 million shares at $24 to $26 each and to list on the New York Stock Exchange under the symbol HAWK. The move comes as the IPO market…

Oruka Therapeutics Shares Jump After Strong Week 16 Psoriasis Results

Oruka Therapeutics Shares Jump After Strong Week 16 Psoriasis Results

Oruka Therapeutics' stock climbed sharply after the company reported positive Week 16 results from the EVERLAST-A Phase 2a trial of ORKA-001 in moderate-to-severe plaque psoriasis. The study met its primary endpoint, with a majority of treated patients achieving complete skin clearance and secondary endpoints showing deep clinical responses. Safety…

Wolfe Sees Energy Sector Primed to Rebound After Sharp Pullback

Wolfe Sees Energy Sector Primed to Rebound After Sharp Pullback

Wolfe Research reports that energy stocks found buying support after approaching oversold territory last week. The firm highlights the sector's ability to reclaim the 50-day moving average this week as a key test that will help determine whether the move is a short-lived relief rally or the start of a renewed uptrend. A recent washout left more tha…

AI-Selected April Picks Deliver Double- and Triple-Digit Momentum; High-Conviction Names Lead Gains

AI-Selected April Picks Deliver Double- and Triple-Digit Momentum; High-Conviction Names Lead Gains

In a turbulent month for markets marked by earnings, geopolitical uncertainty tied to the US/Iran ceasefire, and a re-evaluation of long-term interest rates, an AI-driven selection process delivered exceptional short-term returns. Subscribers to the InvestingPro AI stock lists received April recommendations that produced ten winners up more than 30…

Seaport Therapeutics Seeks $912 Million Valuation in Nasdaq IPO

Seaport Therapeutics Seeks $912 Million Valuation in Nasdaq IPO

Seaport Therapeutics, a clinical-stage biotechnology company based in Boston, has filed for a U.S. initial public offering that would value the company at $912 million. The firm is proposing to sell 11.8 million shares at $16 to $18 each to raise up to $212.4 million, and plans to list on the Nasdaq Global Market under the symbol SPTX. The filing c…

JPMorgan Says Geopolitical-Driven Dips Are Buying Opportunities for Equities

JPMorgan Says Geopolitical-Driven Dips Are Buying Opportunities for Equities

JPMorgan's equity strategy team, led by Mislav Matejka, is urging investors to treat market weakness tied to the Middle East conflict as a buying opportunity rather than a trigger to turn defensive. The bank highlights constraints on a prolonged military confrontation, a milder wages and inflation backdrop than in 2022, policy rates near historical…

Supreme Court To Hear Bayer Appeal Over Roundup Failure-to-Warn Claims

Supreme Court To Hear Bayer Appeal Over Roundup Failure-to-Warn Claims

The U.S. Supreme Court will consider Bayer AG’s bid to block thousands of state-law suits that allege the company failed to warn consumers that glyphosate, the active ingredient in Roundup, causes cancer. Central to the appeal is whether the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) preempts state failure-to-warn claims after the E…

Oil-driven cost surge forces consumer companies into pricing test

Oil-driven cost surge forces consumer companies into pricing test

A fresh jump in energy and commodity costs tied to the Middle East conflict is putting the fragile consumer demand recovery at risk. Procter & Gamble signalled about a $1 billion hit to fiscal 2027 profit from higher crude-related input and logistics costs, and a range of consumer goods firms are weighing whether to raise prices, run promotions or …